Jaguar Health Subsidiary Receiving Preclinical Services from the National Institute of Allergy and Infectious Diseases for New Preclinical Study Initiated July 21, 2020 for Lechlemer Plant-based Drug Candidate for Cholera
SAN FRANCISCO, CA / ACCESSWIRE / July 22, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or…